Edition:
United Kingdom

Fate Therapeutics Inc (FATE.OQ)

FATE.OQ on NASDAQ Stock Exchange Global Market

14.49USD
17 Oct 2018
Change (% chg)

$-0.08 (-0.55%)
Prev Close
$14.57
Open
$14.54
Day's High
$14.54
Day's Low
$13.87
Volume
147,522
Avg. Vol
208,204
52-wk High
$16.82
52-wk Low
$3.82

Chart for

About

Fate Therapeutics, Inc. (Fate Therapeutics) is a clinical-stage biopharmaceutical company. The Company is engaged in development of programmed cellular immunotherapies for cancer and immune disorders. The Company's cell therapy pipeline consists of immuno-oncology programs, including cancer immunotherapies derived from... (more)

Overall

Beta: 1.51
Market Cap(Mil.): $170.63
Shares Outstanding(Mil.): 41.42
Dividend: --
Yield (%): --

Financials

  FATE.OQ Industry Sector
P/E (TTM): -- 85.92 33.73
EPS (TTM): -0.96 -- --
ROI: -72.35 0.63 14.31
ROE: -93.05 1.68 16.04

BRIEF-Fate Therapeutics Files For Mixed Shelf Of Up To $150 Million

* FATE THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $150 MILLION – SEC FILING Source text: (https://bit.ly/2KD5gGz) Further company coverage:

04 May 2018

Earnings vs. Estimates